Posts for Category: Clinical
Get the latest news and read stories from across the country.
Welcome to our blog, where you can stay up to date with all the latest Pharmacy Alternatives news.
New Drug: Digital Inhaler Approved For Asthma Treatment
Teva Industries, Ltd. has received approval for its AirDuo Digihaler (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a... Read more »
Arthritis Tied to Heart Disease
Osteoarthritis has been linked to an increased risk for cardiovascular disease, and a new study suggests that a large part of... Read more »
Can Fixing Sleep Apnea Affect Depression?
Depression and anxiety, both as symptoms and as formal disorders, are elevated in patients with chronic medical disorders, including obstructive sleep... Read more »
Whole Body Vibration Shakes Reduces Diabetes Inflammation
In the face of diabetes, in which glucose and levels of destructive inflammation soar, whole body vibration appears to improve how... Read more »
Estrogen Patches and Schizophrenia
Adjunctive estrogen patches significantly improve positive and negative symptoms of schizophrenia in premenopausal women, new research suggests. The study, a randomized... Read more »
New Drug: Midazolam Nasal Spray (Nayzilam)
The FDA has approved midazolam nasal spray (Nayzilam, for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (seizure... Read more »
Pain Management: A Review of Tramadol and Associated Seizure
Tramadol was approved in 1995 by the FDA. Indicated to treat pain, it was classified as a “nonscheduled opioid” until 2014,... Read more »
First Responders Turn To Weighted Blankets For Those With Special Needs
With claims that they help with sleep, anxiety and stress, the popularity of weighted blankets increased markedly in 2018. Now, local... Read more »
Why Women’s Risk of Alzheimer’s Differs From Men
Two-thirds of U.S. Alzheimer’s cases are women, and it’s not just because they live longer. New research offers some biological clues... Read more »
New Drug: Bagsimi
The FDA has approved the first nasally administered glucagon product (Baqsimi), for the treatment of severe hypoglycemia for patients aged 4... Read more »